Pure Global

Everolimus Eluting Coronary Stent System - India CDSCO Medical Device Registration

Everolimus Eluting Coronary Stent System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2019/000057_c87d460d00d3564b32bb8aea8cee3662_f4321c0d679f5ec7c949f7f9165e9612. This device is marketed under the brand name TM under process. The license holder is KAMAL ENCON INDUSTRIES LIMITED, and it is classified as Device Class Class D. The approving authority is Sub Zonal Baddi.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class D
Everolimus Eluting Coronary Stent System
UID: MFG/MD/2019/000057_c87d460d00d3564b32bb8aea8cee3662_f4321c0d679f5ec7c949f7f9165e9612

Brand Name

TM under process

Device Class

Class D

Approving Authority

Sub Zonal Baddi

Product Information

Everolimus Eluting Coronary Stent system is intended for use in the patient eligible for Percutaneous Transluminal Coronary Angioplasty (TM under process). Everolimus Eluting Coronary Stent System is indicated for improving coronary luminal diameter in patients with symptomatic ischemic disease due to discrete de novo lesions of length โ‰ค 48 mm in native coronary arteries with a reference vessel diameter of 2.00 to 4.50 mm

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing